Where is Intersect ENT's headquarters?

Intersect ENT is located in Menlo Park, California, United States.

Who invested in Intersect ENT?

Intersect ENT has 8 investors including Deerfield And Aisling Capital.

When was the last funding round for Intersect ENT?

Intersect ENT closed its last funding round on obfuscated from a Post-IPO Equity round.

Who are Intersect ENT's competitors?

Alternatives and possible competitors to Intersect ENT may include Aspire Allergy & Sinus, ENT Specialists, And Advanced ENT.

How much funding has Intersect ENT raised to date?

Intersect ENT has raised obfuscated.

Intersect ENT - Financial Details

Financial Details

Highlights

Intersect ENT

is registered under the ticker

NASDAQ:XENT

Intersect ENT

has raised a total of

obfuscation

in funding over

rounds. Their latest funding was raised on

obfuscation

from a

Post-IPO Equity

round.

Intersect ENT

is funded by

investors.

Deerfield

and

Aisling Capital

are the most recent investors.

Intersect ENT

has acquired

Fiagon

obfuscation

. They acquired

Fiagon

for

obfuscation

Stock Symbol

NASDAQ:XENT

Funding Rounds

Total Funding Amount

obfuscation

Lead Investors

Investors

IPO & Stock Price

Stock Symbol

NASDAQ:XENT

Money Raised at IPO

obfuscation

IPO Date

obfuscation

Intersect ENT

is registered under the ticker

NASDAQ:XENT

M&A Details

Intersect ENT

was acquired by

Medtronic

for

obfuscation

. This deal was done in

Cash

Transaction Name

Intersect ENT acquired by Medtronic

Acquired by

Medtronic

Announced Date

obfuscation

Price

obfuscation

Funding Rounds

Number of Funding Rounds

Total Funding Amount

obfuscation

Intersect ENT

has raised a total of

obfuscation

in funding over

rounds. Their latest funding was raised on

obfuscation

from a

Post-IPO Equity

round.

Which funding types raised the most money?

How much funding has this organization raised over time?

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Intersect ENT	1	obfuscated obfuscation	Deerfield	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Intersect ENT	1	obfuscated obfuscation	Deerfield	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Intersect ENT	1	obfuscated obfuscation	Deerfield	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Intersect ENT	1	obfuscated obfuscation	Deerfield	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Intersect ENT	1	obfuscated obfuscation	Deerfield	Post-IPO Equity

Investors

Number of Lead Investors

Number of Investors

Intersect ENT

is funded by

investors.

Deerfield

and

Aisling Capital

are the most recent investors.

Which investors participated in the most funding rounds?

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Deerfield	Yes	Post-IPO Equity - Intersect ENT	—
Deerfield	Yes	Post-IPO Equity - Intersect ENT	—
Deerfield	Yes	Post-IPO Equity - Intersect ENT	—
Deerfield	Yes	Post-IPO Equity - Intersect ENT	—
Deerfield	Yes	Post-IPO Equity - Intersect ENT	—

Acquisitions

Number of Acquisitions

Intersect ENT

has acquired

Fiagon

obfuscation

. They acquired

Fiagon

for

obfuscation

Which types of acquisition does this organization make most frequently?

Acquiree Name	Announced Date	Price	Transaction Name
Fiagon	obfuscated obfuscation	obfuscated obfuscation	Fiagon acquired by Intersect ENT